The FDA has advised California-based Green Pharmaceuticals to recall its SnoreStop nasal spray due to “significant microbial contamination in SnoreStop Nasal Spray lot number 2460” detected during an inspection in April 2024 and is warning customers not to use the product. The FDA notes that the homeopathic product is unapproved and that Green previously recalled a lot of SnoreStop, then called SnoreStop NasoSpray, in 2022 due to contamination with Providencia rettgeri.
Despite the fact that the FDA “reiterated its recall recommendation multiple times,” Green has failed to issue a recall for the nasal spray, which was sold on its own and other web sites. The company is currently not selling the nasal spray on its site, however, and has destroyed product that had not yet been distributed. The SnoreStop site promotes the brand, which also includes a throat spray and chewable tablets, as “The Most Trusted Anti-Snoring Brand Since 1995.”
Read the FDA press release.
